Ring-shaped extrachromosomal DNA is implicated in many cancers. Rachel Brazil talks to the scientists trying to uncover their ...
While both are called medullary carcinoma, these cancers differ in many ways: ...
Oncogene permanent activation in a single targeted cell of zebrafish together with a reprogramming factor transient activation is sufficient to induce the malignant transformation of the cell and ...
POTENTIATE trial ongoing in patients with oncogene amplified cancers, with initial proof of concept data expected in the second half of 2025 Novel Kinesin program progressing toward development ...
A quarter of cancer patients don’t respond to targeted therapies. This biotech wants to help them.
At JP Morgan this year, pharmaphorum caught up with Zach Hornby, the CEO of Boundless Bio, a company focused on oncogene amplification, an under-studied genetic driver in cancer. pharmaphorum ...
According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during ...
Nuvectis Pharma, Inc.’s NVCT share price has dipped by 11.52%, which has investors questioning if this is right time to buy.
14d
Fintel on MSNLeerink Partners Initiates Coverage of Nurix Therapeutics (NRIX) with Market Perform RecommendationFintel reports that on March 17, 2025, Leerink Partners initiated coverage of Nurix Therapeutics (NasdaqGM:NRIX) with a ...
Marek's disease can be pervasive in chicken houses. Chickens infected by this highly contagious viral disease often develop ...
Trump misstated $8 million spent on transgender mice, sparking debate on transgenic research and its importance in science.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results